Get started
Author

Lucie Coster

ORCID: 0000-0001-7993-7485
Observed ORCID: 0000-0001-7993-7485
OpenAlex ID: A5012769406
PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice
2018 · Laura Jamrog, Guillaume Chemin, et al. · Proceedings of the National Academy of Sciences · 38
PDF
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance
2022 · Victor‐Emmanuel Brett, Nicolas Lechevalier, et al. · Genes Chromosomes and Cancer · 8
Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry
2026 · Maël Heiblig, Zofia Gross, et al. · Leukemia · 4
PDF
Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
2023 · Wendy Cuccuini, Marie-Agnes Collonge-Rame, et al. · Current Research in Translational Medicine · 2
A case of cup‐like blasts associated with B‐lymphoblastic leukemia without NPM1 and FLT3 internal tandem duplication mutations
2020 · Jean‐Baptiste Rieu, Lucie Coster, et al. · eJHaem · 2
Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)
2021 · Lucie Coster, Véronique Mansat‐De MAS, et al. · eJHaem · 1
An ETV6::NTRK3 fusion transcript in a core‐binding factor acute myeloid leukemia
2023 · Lucie Coster, Françoise Huguet, et al. · eJHaem
PDF
Massive bone marrow involvement with blastic cells does not always define an acute leukaemia
2023 · Lucie Coster, Solène Evrard, et al. · Annales de biologie clinique
“Accelerated phase” chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies
2022 · Léopoldine Lapierre, Charlotte Syrykh, et al. · Hematological Oncology
Second AML with disseminated intravascular coagulation and blast erythrophagocytosis revealing a t(8,16) KAT6A/CREBBP
2022 · Jean-Baptiste Rieu, Inès Vergnolle, et al. · Annales de biologie clinique
PDF
Author response for "“Accelerated phase” chronic lymphocytic leukemia: still an intermediate risk disease in the era of targeted therapies"
2022 · Léopoldine Lapierre, Charlotte Syrykh, et al. · Publons reviews and discussion
Author response for "“Accelerated phase” chronic lymphocytic leukemia: still an intermediate risk disease in the era of targeted therapies"
2022 · Léopoldine Lapierre, Charlotte Syrykh, et al. · Publons reviews and discussion
Utilisation de la CGH/SNP array dans les leucémies aigues lymphoblastiques pédiatriques : perspectives et limites
2018 · Lucie Coster
Works count: 13
Citation count: 55
H-index: 3
I10-index: 1
Year
Topic
Type